🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 5 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/11/2020 | 141,18 | 141,80 | 140,17 | 141,48 | +1,08% | 1,15% | 247.300 |
| 12/11/2020 | 139,72 | 141,00 | 139,36 | 139,97 | -0,13% | 1,17% | 470.200 |
| 11/11/2020 | 140,05 | 140,30 | 137,93 | 140,15 | +0,62% | 1,69% | 356.500 |
| 10/11/2020 | 136,67 | 139,79 | 136,07 | 139,28 | +2,22% | 2,72% | 459.300 |
| 09/11/2020 | 136,57 | 138,06 | 133,81 | 136,26 | +0,28% | 3,11% | 546.900 |
| 06/11/2020 | 137,71 | 138,45 | 135,38 | 135,88 | -1,33% | 2,23% | 224.100 |
| 05/11/2020 | 140,12 | 140,15 | 136,69 | 137,71 | -1,26% | 2,47% | 548.600 |
| 04/11/2020 | 137,43 | 142,34 | 134,10 | 139,47 | +2,18% | 6,00% | 479.100 |
| 03/11/2020 | 133,98 | 137,34 | 131,96 | 136,50 | +1,88% | 4,02% | 380.800 |
| 02/11/2020 | 133,77 | 135,00 | 130,84 | 133,98 | -0,19% | 3,11% | 466.300 |
| 30/10/2020 | 129,33 | 134,73 | 128,23 | 134,23 | +3,06% | 5,03% | 786.300 |
| 29/10/2020 | 133,35 | 133,67 | 128,22 | 130,25 | -1,35% | 4,09% | 934.600 |
| 28/10/2020 | 121,75 | 132,99 | 121,75 | 132,03 | +6,99% | 9,23% | 1.151.300 |
| 27/10/2020 | 123,13 | 124,50 | 121,48 | 123,40 | -0,14% | 2,45% | 466.900 |
| 26/10/2020 | 122,01 | 124,43 | 120,76 | 123,57 | +0,64% | 3,01% | 602.900 |
| 23/10/2020 | 123,10 | 123,87 | 121,85 | 122,78 | +0,56% | 1,64% | 383.000 |
| 22/10/2020 | 119,34 | 122,28 | 119,34 | 122,10 | +2,73% | 2,46% | 588.400 |
| 21/10/2020 | 119,57 | 121,00 | 118,63 | 118,85 | -0,27% | 1,98% | 686.500 |
| 20/10/2020 | 117,42 | 120,11 | 115,53 | 119,17 | +2,32% | 3,90% | 641.600 |
| 19/10/2020 | 115,54 | 116,86 | 114,18 | 116,47 | +1,28% | 2,32% | 658.700 |
| 16/10/2020 | 113,59 | 115,69 | 112,27 | 115,00 | +1,74% | 3,01% | 536.100 |
| 15/10/2020 | 108,61 | 113,35 | 108,60 | 113,03 | +2,79% | 4,37% | 587.100 |
| 14/10/2020 | 108,16 | 110,66 | 108,16 | 109,96 | +1,51% | 2,31% | 589.100 |
| 13/10/2020 | 104,35 | 109,00 | 103,26 | 108,32 | +3,90% | 5,50% | 441.300 |
| 12/10/2020 | 103,73 | 104,52 | 102,25 | 104,25 | +0,23% | 2,19% | 350.200 |
| 09/10/2020 | 105,01 | 105,44 | 102,91 | 104,01 | -0,84% | 2,41% | 206.700 |
| 08/10/2020 | 104,18 | 105,15 | 103,65 | 104,89 | +0,98% | 1,44% | 200.900 |
| 07/10/2020 | 103,59 | 104,32 | 103,06 | 103,87 | +0,78% | 1,22% | 236.900 |
| 06/10/2020 | 105,87 | 106,60 | 102,73 | 103,07 | -2,48% | 3,66% | 276.900 |
| 05/10/2020 | 102,83 | 105,85 | 102,83 | 105,69 | +3,75% | 2,94% | 423.900 |